Cargando…

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients

Phenylketonuria (PKU) is treated with dietary restrictions and sometimes tetrahydrobiopterin (BH4). PKU patients are at risk for developing micronutrient deficiencies, such as vitamin B12 and folic acid, likely due to their diet. Tyrosinemia type 1 (TT1) is similar to PKU in both pathogenesis and tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Vliet, Kimber, Rodenburg, Iris L., van Ginkel, Willem G., Lubout, Charlotte M.A., Wolffenbuttel, Bruce H.R., van der Klauw, Melanie M., Heiner-Fokkema, M. Rebecca, van Spronsen, Francjan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769775/ https://www.ncbi.nlm.nih.gov/pubmed/31461828 http://dx.doi.org/10.3390/nu11092011

Ejemplares similares

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1
por: van Ginkel, Willem G., et al.
Publicado: (2017)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
por: van Ginkel, Willem G., et al.
Publicado: (2019)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
por: van Ginkel, Willem G., et al.
Publicado: (2019)

The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
por: Kienstra, Nienke S., et al.
Publicado: (2017)

Preventive use of nitisinone in alkaptonuria
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2021)

Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
por: van Vliet, Kimber, et al.
Publicado: (2020)

The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult Pah-Enu2 Mice
por: van Vliet, Danique, et al.
Publicado: (2019)

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
por: van Vliet, Kimber, et al.
Publicado: (2022)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice
por: van Vliet, Danique, et al.
Publicado: (2015)

The Many Faces of Cobalamin (Vitamin B(12)) Deficiency
por: Wolffenbuttel, Bruce H.R., et al.
Publicado: (2019)

Communication of an Abnormal Metabolic New-Born Screening Result in The Netherlands: The Parental Perspective
por: Haitjema, Sietske, et al.
Publicado: (2022)

Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice
por: Bruinenberg, Vibeke M., et al.
Publicado: (2017)

Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe
por: van Vliet, Kimber, et al.
Publicado: (2020)

Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah(enu2) Mice
por: van der Goot, Els, et al.
Publicado: (2022)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
por: Sarodaya, Neha, et al.
Publicado: (2020)

Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype
por: Anjema, Karen, et al.
Publicado: (2013)

Bone mineral density is within normal range in most adult phenylketonuria patients
por: Lubout, Charlotte M. A., et al.
Publicado: (2020)

Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)
por: Bruinenberg, Vibeke M., et al.
Publicado: (2019)

Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2018)

A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?
por: Anjema, Karen, et al.
Publicado: (2016)

Single amino acid supplementation in aminoacidopathies: a systematic review
por: van Vliet, Danique, et al.
Publicado: (2014)

Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis
por: de Groot, Martijn J, et al.
Publicado: (2013)

Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
por: Delsoglio, Marta, et al.
Publicado: (2023)

Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life
por: ten Hoedt, Amber E., et al.
Publicado: (2011)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
por: Mazzola, Priscila Nicolao, et al.
Publicado: (2015)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results
por: Giżewska, Maria, et al.
Publicado: (2015)

Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011)

The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2020)

Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria
por: Pinto, Alex, et al.
Publicado: (2019)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Plasma carnitine concentrations in Medium‐chain acyl‐CoA dehydrogenase deficiency: lessons from an observational cohort study
por: Jager, Emmalie A., et al.
Publicado: (2022)

The complete European guidelines on phenylketonuria: diagnosis and treatment
por: van Wegberg, A. M. J., et al.
Publicado: (2017)

Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study
por: Jahja, Rianne, et al.
Publicado: (2016)

Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
por: Jahja, Rianne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8p7eiua0cqt58bhmi0k58dj4in